13
Nov
Cibus Therapeutics and Greenstone Biosciences Announce First Participant Dosed in Phase 1 Trial of CBT-248 (GSB-D248), an Investigational Oral Anti-Inflammatory Therapy for Chronic Pancreatitis
Cibus Therapeutics and Greenstone Biosciences today announced that the first participan...